US FDA publishes Draft Guidance for Industry on Drug Products, Including Biological Products, that Contain Nanomaterials
Nanotechnology Industries Association – The United States Federal Drug Administration has published a draft Guidance on Drug Products, Including Biological Products, that Contain Nanomaterials on 18 December 2017.
This Guidance for Industry outlines potential risk factors for drugs containing nanomaterials. It also provides recommendations on quality aspects, environmental impact as well as guidance for both non-clinical and clinical testing.
Read more at Nanotechnology Industries Association.